Cargando…
Comprehensive Identification of Tumor-associated Antigens via Isolation of Human Monoclonal Antibodies that may be Therapeutic
Although the success of trastuzumab and rituximab for treatment of breast cancer and non-Hodgkins lymphoma, respectively, suggests that monoclonal antibodies (mAbs) will become important therapeutic agents against a wider range of cancers, useful therapeutic Abs are not yet available for the majorit...
Autor principal: | Kurosawa, Yoshikazu |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunobiologists
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803294/ https://www.ncbi.nlm.nih.gov/pubmed/20107531 http://dx.doi.org/10.4110/in.2009.9.1.4 |
Ejemplares similares
-
Conditions of tumor-associated antigens as a proper target for therapeutic antibodies against solid cancers
por: Kurosawa, Y
Publicado: (2011) -
Rapid production of antigen-specific monoclonal antibodies from a variety of animals
por: Kurosawa, Nobuyuki, et al.
Publicado: (2012) -
Radiolabeled Human Monoclonal Antibody 067-213 has the Potential for Noninvasive Quantification of CD73 Expression
por: Sudo, Hitomi, et al.
Publicado: (2020) -
Human monoclonal antibodies to lung-cancer antigens.
por: Sikora, K., et al.
Publicado: (1981) -
A Novel Human Monoclonal Antibody Directed to a Tumor‐associated Antigen
por: Kudo, Toshio, et al.
Publicado: (1993)